$SNCA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PALISADE BIO, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PALISADE BIO, INC.. Get notifications about new insider transactions in PALISADE BIO, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 07 2014 | CUR | Neuralstem, Inc. | SMITH SANDFORD D | Director | Option Exercise | A | 3.01 | 74,367 | 223,845 | 74,367 | |
Aug 04 2014 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 2.78 | 6,000 | 16,680 | 484,247 | 490.2 K to 484.2 K (-1.22 %) |
Jul 01 2014 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 4.17 | 6,000 | 25,020 | 490,247 | 496.2 K to 490.2 K (-1.21 %) |
Jun 11 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 12,000 | 0 | 1,237,337 | 1.2 M to 1.2 M (-0.96 %) |
Jun 02 2014 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 4.25 | 6,000 | 25,500 | 496,247 | 502.2 K to 496.2 K (-1.19 %) |
May 07 2014 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 3.50 | 985 | 3,448 | 985 | 0 to 985 |
May 07 2014 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 3.50 | 14,250 | 49,874 | 116,939 | 102.7 K to 116.9 K (+13.88 %) |
May 05 2014 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 3.54 | 6,000 | 21,255 | 502,247 | 508.2 K to 502.2 K (-1.18 %) |
Apr 23 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Sell | S | 4.25 | 7,000 | 29,750 | 240,000 | 247 K to 240 K (-2.83 %) |
Apr 11 2014 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | M | 3.30 | 20,000 | 66,000 | 0 | |
Apr 11 2014 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Payment of Exercise | F | 4.66 | 9,871 | 45,999 | 99,429 | 109.3 K to 99.4 K (-9.03 %) |
Apr 11 2014 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | M | 3.30 | 20,000 | 66,000 | 109,300 | 89.3 K to 109.3 K (+22.40 %) |
Apr 11 2014 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | M | 3.30 | 20,000 | 66,000 | 0 | |
Apr 11 2014 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Payment of Exercise | F | 4.66 | 14,163 | 66,000 | 20,837 | 35 K to 20.8 K (-40.47 %) |
Apr 11 2014 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Buy | M | 3.30 | 20,000 | 66,000 | 35,000 | 15 K to 35 K (+133.33 %) |
Apr 04 2014 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 17,500 | 0 | 508,247 | 525.7 K to 508.2 K (-3.33 %) |
Apr 02 2014 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 4.11 | 6,000 | 24,638 | 525,747 | 531.7 K to 525.7 K (-1.13 %) |
Mar 28 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 5,000 | 0 | 247,000 | 252 K to 247 K (-1.98 %) |
Mar 21 2014 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 4.04 | 6,000 | 24,249 | 531,747 | 537.7 K to 531.7 K (-1.12 %) |
Feb 04 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Option Exercise | A | 3.22 | 193,158 | 621,969 | 193,158 | |
Feb 04 2014 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Option Exercise | A | 3.22 | 200,324 | 645,043 | 200,324 | |
Jan 27 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Option Exercise | M | 0.50 | 400,000 | 200,000 | 800,000 | |
Jan 27 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Payment of Exercise | F | 3.04 | 65,789 | 199,999 | 1,389,538 | 1.5 M to 1.4 M (-4.52 %) |
Jan 27 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Buy | M | 0.50 | 400,000 | 200,000 | 1,455,327 | 1.1 M to 1.5 M (+37.90 %) |
Dec 05 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 4,000 | 0 | 680,994 | 685 K to 681 K (-0.58 %) |
Nov 07 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 2.35 | 10,000 | 23,458 | 684,994 | 695 K to 685 K (-1.44 %) |
Oct 21 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 2.44 | 10,000 | 24,446 | 694,994 | 705 K to 695 K (-1.42 %) |
Sep 23 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 2.62 | 10,000 | 26,241 | 704,994 | 715 K to 705 K (-1.40 %) |
Sep 19 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 2.61 | 10,000 | 26,094 | 714,994 | 725 K to 715 K (-1.38 %) |
Sep 04 2013 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 50,000 | 0 | 252,000 | 202 K to 252 K (+24.75 %) |
Sep 04 2013 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 13,000 | 0 | 1,055,327 | 1.1 M to 1.1 M (-1.22 %) |
Sep 04 2013 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 13,000 | 0 | 1,068,327 | 1.1 M to 1.1 M (-1.20 %) |
Sep 04 2013 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 50,000 | 0 | 1,081,327 | 1.1 M to 1.1 M (-4.42 %) |
Sep 04 2013 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Sell | J | 0.00 | 150,000 | 0 | 1,131,327 | 1.3 M to 1.1 M (-11.71 %) |
Aug 21 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.55 | 20,000 | 30,986 | 724,994 | 745 K to 725 K (-2.68 %) |
Jul 22 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.62 | 12,800 | 20,780 | 744,994 | 757.8 K to 745 K (-1.69 %) |
Jun 21 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.40 | 12,800 | 17,856 | 757,794 | 770.6 K to 757.8 K (-1.66 %) |
May 21 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.51 | 12,800 | 19,301 | 770,594 | 783.4 K to 770.6 K (-1.63 %) |
Jun 11 2013 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 5,000 | 0 | 202,000 | 207 K to 202 K (-2.42 %) |
Jun 11 2013 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Sell | S | 1.42 | 6,000 | 8,520 | 207,000 | 213 K to 207 K (-2.82 %) |
May 09 2013 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 1.13 | 35,000 | 39,550 | 35,000 | |
May 09 2013 | CUR | Neuralstem, Inc. | WESTREICH STANLEY | Director | Option Exercise | A | 1.13 | 35,000 | 39,550 | 35,000 | |
Apr 23 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.13 | 12,800 | 14,520 | 783,394 | 796.2 K to 783.4 K (-1.61 %) |
May 09 2013 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 1.13 | 35,000 | 39,550 | 35,000 | |
Apr 10 2013 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Option Exercise | A | 1.12 | 571,033 | 639,557 | 571,033 | |
Apr 10 2013 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Option Exercise | A | 1.12 | 129,327 | 144,846 | 129,327 | |
Apr 10 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Option Exercise | A | 1.12 | 592,219 | 663,285 | 592,219 | |
Feb 26 2013 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Sell | S | 1.15 | 12,000 | 13,800 | 213,000 | 225 K to 213 K (-5.33 %) |
Mar 22 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.14 | 12,800 | 14,546 | 796,194 | 809 K to 796.2 K (-1.58 %) |
Feb 21 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.18 | 12,800 | 15,104 | 808,994 | 821.8 K to 809 K (-1.56 %) |
Jan 23 2013 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.27 | 12,800 | 16,256 | 821,794 | 834.6 K to 821.8 K (-1.53 %) |
Dec 26 2012 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.16 | 12,800 | 14,822 | 834,594 | 847.4 K to 834.6 K (-1.51 %) |
Nov 27 2012 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.00 | 12,800 | 12,800 | 847,394 | 860.2 K to 847.4 K (-1.49 %) |
Jul 27 2012 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 3,000 | 0 | 1,278,327 | 1.3 M to 1.3 M (-0.23 %) |
Jul 27 2012 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Sell | J | 0.00 | 120,821 | 0 | 1,281,327 | 1.4 M to 1.3 M (-8.62 %) |
Jul 27 2012 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Option Exercise | A | 0.92 | 5,000,000 | 4,600,000 | 5,000,000 | |
Jun 22 2012 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 14,000 | 0 | 1,374,148 | 1.4 M to 1.4 M (-1.01 %) |
Jun 22 2012 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 14,000 | 0 | 1,388,148 | 1.4 M to 1.4 M (-1.00 %) |
Jun 20 2012 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | J | 0.00 | 256,790 | 0 | 860,194 | 1.1 M to 860.2 K (-22.99 %) |
Nov 16 2011 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | J | 0.00 | 745,000 | 0 | 1,126,984 | 1.9 M to 1.1 M (-39.80 %) |
Feb 03 2011 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Grant | A | 0.00 | 18,565 | 0 | 115,492 | 96.9 K to 115.5 K (+19.15 %) |
Feb 03 2011 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Grant | A | 0.00 | 19,802 | 0 | 1,588,072 | 1.6 M to 1.6 M (-1.23 %) |
Dec 29 2010 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 5,000 | 0 | 1,568,270 | 1.6 M to 1.6 M (-0.32 %) |
Dec 29 2010 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 5,000 | 0 | 1,573,270 | 1.6 M to 1.6 M (-0.32 %) |
Dec 29 2010 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 50,000 | 0 | 1,578,270 | 1.6 M to 1.6 M (-3.07 %) |
Nov 23 2010 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Option Exercise | A | 2.21 | 263,147 | 581,555 | 263,147 | |
Nov 23 2010 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Grant | A | 0.00 | 138,122 | 0 | 1,628,270 | 1.5 M to 1.6 M (+9.27 %) |
Nov 23 2010 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Option Exercise | A | 2.21 | 272,909 | 603,129 | 272,909 | |
Nov 23 2010 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Grant | A | 0.00 | 143,247 | 0 | 1,871,984 | 1.7 M to 1.9 M (+8.29 %) |
Nov 23 2010 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Option Exercise | A | 2.21 | 65,948 | 145,745 | 65,948 | |
Nov 23 2010 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Grant | A | 0.00 | 34,615 | 0 | 96,927 | 62.3 K to 96.9 K (+55.55 %) |
Nov 23 2010 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 2.51 | 15,000 | 37,650 | 35,000 | |
Nov 23 2010 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 2.51 | 20,000 | 50,200 | 20,000 | |
Nov 23 2010 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Nov 23 2010 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 2.51 | 15,000 | 37,650 | 35,000 | |
Nov 23 2010 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 2.51 | 20,000 | 50,200 | 20,000 | |
Nov 23 2010 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Grant | A | 0.00 | 15,000 | 0 | 104,300 | 89.3 K to 104.3 K (+16.80 %) |
Sep 20 2010 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 2.31 | 2,500 | 5,775 | 89,300 | 86.8 K to 89.3 K (+2.88 %) |
Sep 20 2010 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 2.32 | 7,500 | 17,400 | 86,800 | 79.3 K to 86.8 K (+9.46 %) |
Jul 12 2010 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Grant | A | 0.00 | 10,948 | 0 | 62,312 | 51.4 K to 62.3 K (+21.31 %) |
Jul 12 2010 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Grant | A | 0.00 | 33,253 | 0 | 1,728,737 | 1.7 M to 1.7 M (+1.96 %) |
Jul 12 2010 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Grant | A | 0.00 | 76,953 | 0 | 1,490,148 | 1.4 M to 1.5 M (+5.45 %) |
Jan 04 2010 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Buy | P | 1.65 | 189,111 | 312,033 | 1,413,195 | 1.2 M to 1.4 M (+15.45 %) |
Jan 04 2010 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Buy | P | 1.65 | 36,364 | 60,001 | 51,364 | 15 K to 51.4 K (+242.43 %) |
Sep 25 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 10,000 | 0 | 1,695,484 | 1.7 M to 1.7 M (-0.59 %) |
Jul 22 2009 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 1.17 | 15,000 | 17,550 | 130,000 | |
Jul 22 2009 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 1.17 | 20,000 | 23,400 | 115,000 | |
Jul 22 2009 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 1.17 | 15,000 | 17,550 | 190,000 | |
Jul 22 2009 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 1.17 | 20,000 | 23,400 | 175,000 | |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,000 | 0 | 1,705,484 | 1.7 M to 1.7 M (-0.18 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,708,484 | 1.7 M to 1.7 M (-0.06 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,709,484 | 1.7 M to 1.7 M (-0.06 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,710,484 | 1.7 M to 1.7 M (-0.06 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 9,000 | 0 | 1,711,484 | 1.7 M to 1.7 M (-0.52 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,000 | 0 | 1,720,484 | 1.7 M to 1.7 M (-0.17 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,723,484 | 1.7 M to 1.7 M (-0.06 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,724,484 | 1.7 M to 1.7 M (-0.06 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,000 | 0 | 1,725,484 | 1.7 M to 1.7 M (-0.17 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 9,000 | 0 | 1,728,484 | 1.7 M to 1.7 M (-0.52 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 9,000 | 0 | 1,737,484 | 1.7 M to 1.7 M (-0.52 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 9,000 | 0 | 1,746,484 | 1.8 M to 1.7 M (-0.51 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,000 | 0 | 1,755,484 | 1.8 M to 1.8 M (-0.17 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,000 | 0 | 1,758,484 | 1.8 M to 1.8 M (-0.17 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,761,484 | 1.8 M to 1.8 M (-0.06 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,762,484 | 1.8 M to 1.8 M (-0.06 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,000 | 0 | 1,763,484 | 1.8 M to 1.8 M (-0.17 %) |
Apr 20 2009 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,000 | 0 | 1,766,484 | 1.8 M to 1.8 M (-0.17 %) |
Dec 31 2008 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 186,000 | 0 | 1,224,084 | 1.4 M to 1.2 M (-13.19 %) |
Dec 31 2008 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 7,000 | 0 | 1,410,084 | 1.4 M to 1.4 M (-0.49 %) |
Dec 31 2008 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 7,000 | 0 | 1,417,084 | 1.4 M to 1.4 M (-0.49 %) |
Aug 22 2008 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 1.77 | 2,200 | 3,894 | 68,400 | 66.2 K to 68.4 K (+3.32 %) |
Aug 22 2008 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 1.79 | 3,000 | 5,370 | 66,200 | 63.2 K to 66.2 K (+4.75 %) |
Aug 22 2008 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 1.82 | 500 | 910 | 63,200 | 62.7 K to 63.2 K (+0.80 %) |
Aug 22 2008 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 1.83 | 1,500 | 2,745 | 62,700 | 61.2 K to 62.7 K (+2.45 %) |
Aug 22 2008 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 1.87 | 3,000 | 5,610 | 61,200 | 58.2 K to 61.2 K (+5.15 %) |
Jul 10 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Buy | P | 1.46 | 1,700 | 2,482 | 15,000 | 13.3 K to 15 K (+12.78 %) |
Jul 10 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Buy | P | 1.43 | 500 | 715 | 13,300 | 12.8 K to 13.3 K (+3.91 %) |
Jul 10 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Buy | P | 1.41 | 600 | 846 | 12,800 | 12.2 K to 12.8 K (+4.92 %) |
Jul 10 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Buy | P | 1.40 | 625 | 875 | 12,200 | 11.6 K to 12.2 K (+5.40 %) |
Jul 10 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Buy | P | 1.36 | 1,000 | 1,360 | 11,575 | 10.6 K to 11.6 K (+9.46 %) |
Jul 10 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Buy | P | 1.35 | 100 | 135 | 10,575 | 10.5 K to 10.6 K (+0.95 %) |
Jul 10 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Buy | P | 1.32 | 475 | 627 | 10,475 | 10 K to 10.5 K (+4.75 %) |
Jul 07 2008 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO, President | Buy | P | 1.42 | 49,000 | 69,580 | 1,424,084 | 1.4 M to 1.4 M (+3.56 %) |
Jun 02 2008 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 1.32 | 60,000 | 79,200 | 95,000 | |
Jun 05 2008 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 1.95 | 10,000 | 19,500 | 58,200 | 48.2 K to 58.2 K (+20.75 %) |
Jun 02 2008 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 1.32 | 60,000 | 79,200 | 155,000 | |
Jun 02 2008 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 1.60 | 10,000 | 16,000 | 48,200 | 38.2 K to 48.2 K (+26.18 %) |
Apr 24 2008 | CUR | Neuralstem, Inc. | GARR RICHARD | Director | Grant | A | 1.91 | 2,000 | 3,820 | 1,375,084 | 1.4 M to 1.4 M (+0.15 %) |
Apr 03 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Option Exercise | A | 2.60 | 50,000 | 130,000 | 1,150,000 | |
Apr 03 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Option Exercise | A | 2.60 | 333,333 | 866,666 | 1,100,000 | |
Apr 03 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Option Exercise | A | 2.60 | 333,333 | 866,666 | 766,666 | |
Apr 03 2008 | CUR | Neuralstem, Inc. | CONRON JOHN | Chief Financial Off ... | Option Exercise | A | 2.60 | 333,333 | 866,666 | 433,333 | |
Mar 11 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chairman | Option Exercise | A | 3.66 | 700,000 | 2,562,000 | 6,633,333 | |
Mar 11 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chairman | Option Exercise | A | 3.66 | 700,000 | 2,562,000 | 5,933,333 | |
Mar 11 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chairman | Option Exercise | A | 3.66 | 700,000 | 2,562,000 | 5,233,333 | |
Mar 11 2008 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO, President | Option Exercise | A | 3.66 | 700,000 | 2,562,000 | 3,300,000 | |
Mar 11 2008 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO, President | Option Exercise | A | 3.66 | 700,000 | 2,562,000 | 2,600,000 | |
Mar 11 2008 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO, President | Option Exercise | A | 3.66 | 700,000 | 2,562,000 | 1,900,000 | |
Feb 12 2008 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | P | 3.01 | 9,700 | 29,224 | 37,200 | 27.5 K to 37.2 K (+35.27 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,700 | 0 | 1,769,484 | 1.8 M to 1.8 M (-0.21 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,773,184 | 1.8 M to 1.8 M (-0.06 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,774,184 | 1.8 M to 1.8 M (-0.06 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,775,184 | 1.8 M to 1.8 M (-0.06 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,700 | 0 | 1,776,184 | 1.8 M to 1.8 M (-0.21 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,700 | 0 | 1,779,884 | 1.8 M to 1.8 M (-0.21 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,783,584 | 1.8 M to 1.8 M (-0.06 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 1,000 | 0 | 1,784,584 | 1.8 M to 1.8 M (-0.06 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,700 | 0 | 1,785,584 | 1.8 M to 1.8 M (-0.21 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,700 | 0 | 1,789,284 | 1.8 M to 1.8 M (-0.21 %) |
Feb 22 2008 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 3,700 | 0 | 1,792,984 | 1.8 M to 1.8 M (-0.21 %) |